Skip to main content

Animations

MJFF Publications

3781 - 3790 of 9145 Results
Title
Year
  • Year
  • 2018
  • 2019
  • 2024
  • 2019
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2018
  • Summary Details
    OPEN
    Title: The atypical RhoGTPase RhoE/Rnd3 is a key molecule to acquire a neuroprotective phenotype in microglia
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-018-1386-z
    Citation Count: 15
  • Summary Details
    OPEN
    Title: 18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes
    Journal Name: Alzheimer's Research & Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13195-019-0470-7
    Citation Count: 163
  • Summary Details
    OPEN
    Title: Resequencing the complete SNCA locus in Indian patients with Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00676-4
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Basic clinical features do not predict dopamine transporter binding in idiopathic REM behavior disorder
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-018-0073-1
    Citation Count: 32
  • Summary Details
    OPEN
    Title: Fusion of biomedical imaging studies for increased sample size and diversity: a case study of brain MRI
    Journal Name: Frontiers in Radiology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fradi.2024.1283392
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson’s disease
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41591-024-02886-y
    Citation Count: 116
  • Summary Details
    OPEN
    Title: α-Synuclein triggers cofilin pathology and dendritic spine impairment via a PrPC-CCR5 dependent pathway
    Journal Name: Cell Death & Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41419-024-06630-9
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Investigating alpha‐synuclein co‐pathology in Alzheimer's disease by means of cerebrospinal fluid alpha‐synuclein seed amplification assay
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/alz.13658
    Citation Count: 108
  • Summary Details
    OPEN
    Title: Vulnerability of Thalamic Nuclei at CSF Interface During the Entire Course of Multiple Sclerosis
    Journal Name: Neurology Neuroimmunology & Neuroinflammation
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1212/nxi.0000000000200222
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Impaired hepatic amyloid-beta degradation in Alzheimer’s disease
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0203659
    Citation Count: 77
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.